Intermittent letrozole as adjuvant treatment in postmenopausal hormone-receptor positive early breast cancer patients

被引：0
|
作者：
Balduzzi, A.
Bagnardi, V.
Volpe, S.
Cancello, G.
Iorfida, M.
Dellapasqua, S.
Sandri, M.
Goldhirsch, A.
Colleoni, M.
机构：
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P1-13-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-13-12
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Comparison of the efficacy of adjuvant letrozole and anastrozole in hormone-receptor positive postmenopausal breast cancer patients.
    Sendur, Mehmet Ali Nahit
    Aksoy, Sercan
    Altundag, Kadri
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone-receptor positive postmenopausal women with early breast cancer.
    Delea, T. E.
    Karnon, J.
    Sofrygin, O.
    Thomas, S. K.
    Barghout, V
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S116 - S117
  • [3] Cost-effectiveness analysis of letrozole versus tamoxifen as initial adjuvant therapy in hormone-receptor positive postmenopausal women with early breast cancer in the UK
    Karnon, J
    Delea, TE
    Papo, NL
    Barghout, V
    Thomas, SK
    Johnston, SR
    VALUE IN HEALTH, 2005, 8 (06) : A43 - A43
  • [4] Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective
    Delea, Thomas E.
    El-Ouagari, Khalid
    Karnon, Jonathan
    Sofrygin, Oleg
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (03) : 375 - 387
  • [5] Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone-receptor positive postmenopausal women with early breast cancer from a Canadian perspective
    Delea, Thomas E.
    El Ouagari, Khalid
    Karnon, Jon
    Sofrygin, Oleg
    Barghout, Victoria
    ANNALS OF ONCOLOGY, 2006, 17 : 107 - 107
  • [6] Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone-receptor positive postmenopausal women with early breast cancer from a US perspective
    Delea, TE
    Karnon, J
    Thomas, SK
    Barghout, V
    Papo, NL
    Johnston, SRD
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S102 - S102
  • [7] Cost-effectiveness analysis of letrozole versus tamoxifen as initial adjuvant therapy in hormone-receptor positive postmenopausal women with early breast cancer: the UK perspective
    Karnon, J
    Delea, TE
    Barghout, V
    Thomas, SK
    Papo, NL
    Johnston, SRD
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S104 - S104
  • [8] Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective
    Thomas E. Delea
    Khalid El-Ouagari
    Jonathan Karnon
    Oleg Sofrygin
    Breast Cancer Research and Treatment, 2008, 108 : 375 - 387
  • [9] Adjuvant endocrine monotherapy for postmenopausal early breast cancer patients with hormone-receptor positive: a systemic review and network meta-analysis
    Yu, Zhu
    Guo, Xiaojing
    Jiang, Yicheng
    Teng, Lei
    Luo, Jinwu
    Wang, Pengfei
    Liang, Yunsheng
    Zhang, Haitian
    BREAST CANCER, 2018, 25 (01) : 8 - 16
  • [10] Adjuvant endocrine monotherapy for postmenopausal early breast cancer patients with hormone-receptor positive: a systemic review and network meta-analysis
    Zhu Yu
    Xiaojing Guo
    Yicheng Jiang
    Lei Teng
    Jinwu Luo
    Pengfei Wang
    Yunsheng Liang
    Haitian Zhang
    Breast Cancer, 2018, 25 : 8 - 16
12345